These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 20009899)

  • 1. 18F-fluorodeoxyglucose-positron emission tomography and pathologic tumor size in early-stage invasive cervical cancer.
    Showalter TN; Miller TR; Huettner P; Rader J; Grigsby PW
    Int J Gynecol Cancer; 2009 Nov; 19(8):1412-4. PubMed ID: 20009899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of pretreatment 18F-fluorodeoxyglucose uptake in patients with cervical cancer treated with definitive chemoradiotherapy.
    Onal C; Reyhan M; Parlak C; Guler OC; Oymak E
    Int J Gynecol Cancer; 2013 Jul; 23(6):1104-10. PubMed ID: 23792605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validity of 18F-fluorodeoxyglucose positron emission tomography/computed tomography for pretreatment evaluation of patients with cervical carcinoma: a retrospective pathology-matched study.
    Dong Y; Wang X; Wang Y; Liu Y; Zhang J; Qian W; Wu S
    Int J Gynecol Cancer; 2014 Nov; 24(9):1642-7. PubMed ID: 25268748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histologic results of para-aortic lymphadenectomy in patients treated for stage IB2/II cervical cancer with negative [18F]fluorodeoxyglucose positron emission tomography scans in the para-aortic area.
    Boughanim M; Leboulleux S; Rey A; Pham CT; Zafrani Y; Duvillard P; Lumbroso J; Haie-Meder C; Schlumberger M; Morice P
    J Clin Oncol; 2008 May; 26(15):2558-61. PubMed ID: 18487573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. (
    Scher N; Castelli J; Depeursinge A; Bourhis J; Prior JO; Herrera FG; Ozsahin M
    Cancer Radiother; 2018 May; 22(3):229-235. PubMed ID: 29650390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of preoperative intratumoral FDG uptake heterogeneity in early stage uterine cervical cancer.
    Chung HH; Kang SY; Ha S; Kim JW; Park NH; Song YS; Cheon GJ
    J Gynecol Oncol; 2016 Mar; 27(2):e15. PubMed ID: 26768781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preoperative staging of cervical cancer: is 18-FDG-PET/CT really effective in patients with early stage disease?
    Signorelli M; Guerra L; Montanelli L; Crivellaro C; Buda A; Dell'Anna T; Picchio M; Milani R; Fruscio R; Messa C
    Gynecol Oncol; 2011 Nov; 123(2):236-40. PubMed ID: 21855972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of metabolic tumor volume measured by 18F-fluorodeoxyglucose positron emission tomography in patients with esophageal carcinoma.
    Hyun SH; Choi JY; Shim YM; Kim K; Lee SJ; Cho YS; Lee JY; Lee KH; Kim BT
    Ann Surg Oncol; 2010 Jan; 17(1):115-22. PubMed ID: 19826877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 18F-FDG-PET/CT is of limited value in primary staging of early stage cervical cancer.
    Driscoll DO; Halpenny D; Johnston C; Sheehy N; Keogan M
    Abdom Imaging; 2015 Jan; 40(1):127-33. PubMed ID: 25015401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperative lymph-node staging of invasive urothelial bladder cancer with 18F-fluorodeoxyglucose positron emission tomography/computed axial tomography and magnetic resonance imaging: correlation with histopathology.
    Jensen TK; Holt P; Gerke O; Riehmann M; Svolgaard B; Marcussen N; Bouchelouche K
    Scand J Urol Nephrol; 2011 Mar; 45(2):122-8. PubMed ID: 21231796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cervical cancer histology and tumor differentiation affect 18F-fluorodeoxyglucose uptake.
    Kidd EA; Spencer CR; Huettner PC; Siegel BA; Dehdashti F; Rader JS; Grigsby PW
    Cancer; 2009 Aug; 115(15):3548-54. PubMed ID: 19472399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 18-fluoro-deoxy-glucose positron emission tomography with computed tomography-based gross tumor volume estimation and validation with magnetic resonance imaging for locally advanced cervical cancers.
    Upasani MN; Mahantshetty UM; Rangarajan V; Purandare N; Merchant N; Thakur M; Engineer R; Chopra S; Shrivastava SK
    Int J Gynecol Cancer; 2012 Jul; 22(6):1031-6. PubMed ID: 22622949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of volume-based metabolic parameters in uterine cervical cancer determined using 18F-fluorodeoxyglucose positron emission tomography.
    Yoo J; Choi JY; Moon SH; Bae DS; Park SB; Choe YS; Lee KH; Kim BT
    Int J Gynecol Cancer; 2012 Sep; 22(7):1226-33. PubMed ID: 22810970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Whole-body [18F]fluoro-2-deoxyglucose positron emission tomography scan staging prior to planned radical hysterectomy and pelvic lymphadenectomy.
    Unger JB; Ivy JJ; Ramaswamy MR; Charrier A; Connor P
    Int J Gynecol Cancer; 2005; 15(6):1060-4. PubMed ID: 16343182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 18F-FDG PET/CT can predict nodal metastases but not recurrence in early stage uterine cervical cancer.
    Crivellaro C; Signorelli M; Guerra L; De Ponti E; Buda A; Dolci C; Pirovano C; Todde S; Fruscio R; Messa C
    Gynecol Oncol; 2012 Oct; 127(1):131-5. PubMed ID: 22772064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of ¹⁸F-FDG PET/CT in early-stage cervical carcinoma.
    Yu L; Jia C; Wang X; Lu P; Tian M; Wang W; Lou G
    Am J Med Sci; 2011 Feb; 341(2):96-100. PubMed ID: 21030858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in cervical cancer FDG uptake during chemoradiation and association with response.
    Kidd EA; Thomas M; Siegel BA; Dehdashti F; Grigsby PW
    Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):116-22. PubMed ID: 22520475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low value of [18F]-fluoro-2-deoxy-D-glucose positron emission tomography in primary staging of early-stage cervical cancer before radical hysterectomy.
    Chou HH; Chang TC; Yen TC; Ng KK; Hsueh S; Ma SY; Chang CJ; Huang HJ; Chao A; Wu TI; Jung SM; Wu YC; Lin CT; Huang KG; Lai CH
    J Clin Oncol; 2006 Jan; 24(1):123-8. PubMed ID: 16382121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation between FDG-PET/CT findings and solid type non-small cell cancer prognostic factors: are there differences between adenocarcinoma and squamous cell carcinoma?
    Ito R; Iwano S; Kishimoto M; Ito S; Kato K; Naganawa S
    Ann Nucl Med; 2015 Dec; 29(10):897-905. PubMed ID: 26342592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relation between FIGO stage, primary tumor volume, and presence of lymph node metastases in cervical cancer patients referred for radiotherapy.
    Narayan K; McKenzie AF; Hicks RJ; Fisher R; Bernshaw D; Bau S
    Int J Gynecol Cancer; 2003; 13(5):657-63. PubMed ID: 14675351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.